Research News and Research

RSS

ACOEM awareness campaign helps employers identify and respond to chronic diseases

The American College of Occupational and Environmental Medicine (ACOEM) today announced a yearlong awareness-building campaign intended to help employers identify and respond to chronic diseases that commonly impact worker health and productivity.

6 Sep 2012

Patients at hospitals with longer resuscitation attempts have higher survival rates

There isn't a hard and fast rule for how long doctors should perform CPR, but new research from the University of Michigan Health System shows longer attempts might be beneficial for some patients.

6 Sep 2012

Biologic therapies do not increase risk of cancer in patients with rheumatoid arthritis

Biologic therapies developed in the last decade for rheumatoid arthritis are not associated with an increased risk of cancer when compared with traditional treatments for the condition, according to new research from The University of Texas MD Anderson Cancer Center.

6 Sep 2012

Viewpoints: Anti-abortion Democrats praise health law; A defense of the Medicare cost-cutting board

The big question heading into the Democratic Convention is just how forcefully the party will defend the Affordable Care Act, which the president fought to pass and then declined to sell. On Tuesday, an unusually vocal endorsement of the law came from an unlikely source: Anti-abortion Democrats.

6 Sep 2012

UEA, IFR to study protective effects of broccoli consumption against prostate cancer

The Prostate Cancer Foundation is providing $1M of funding to the Institute of Food Research and the University of East Anglia (UEA) to study the protective effects of broccoli consumption against prostate cancer.

6 Sep 2012

Study sheds new light on why most bone marrow transplant patients suffer acute GVHD

A team of scientists led by a bone marrow transplant researcher at Fred Hutchinson Cancer Research Center has shed new light on why most bone marrow transplant patients who receive tissue-matched cells from unrelated donors still suffer acute graft-versus-host disease (GVHD).

6 Sep 2012

ImmunoCellular completes enrollment in ICT-107 Phase II trial for glioblastoma

ImmunoCellular Therapeutics, Ltd. announced today that the company has completed enrollment for its Phase II randomized, double-blinded, placebo-controlled, multi-center trial of its dendritic cell-based cancer vaccine ICT-107 for treatment of glioblastoma.

6 Sep 2012

Medicare beneficiaries who were overcharged for drugs because of CVS' incorrect prices will receive refunds

The Federal Trade Commission said that it is mailing refund checks to 13,000 Medicare Part D beneficiaries who were overcharged for drugs because a CVS Caremark Corp. business understated the price of the medications.

6 Sep 2012

TSC and PTEN genes important in controlling blood precursor cells in Drosophila

UCLA stem cell scientists have shown that two common tumor suppressor genes, TSC and PTEN, are vital to regulating the stem cell-like precursor cells that create the blood supply in Drosophila, the common fruit fly.

6 Sep 2012

Developing countries NGO delegation to Global Fund submits report highlighting challenges, recommendations

The Center for Global Health Policy's "Science Speaks" blog discusses a report by the developing countries NGO delegation to the Global Fund to Fight AIDS, Tuberculosis and Malaria, submitted recently to the Global Fund Secretariat.

6 Sep 2012

Nordion third quarter revenue increases 0.5% to $67.1 million

Nordion Inc., a leading provider of products and services to the global health science market, today reported results for the fiscal third quarter ended July 31, 2012. The Company generated $67.1 million in revenue for the third quarter, an increase of $0.3 million, or 0.5%, over revenue of $66.8 million for the same period in 2011.

6 Sep 2012

DuraSite 2 ophthalmic drug delivery system from InSite Vision

InSite Vision Incorporated today introduced DuraSite 2, its next-generation enhanced drug delivery system which provides a broad platform for developing superior ophthalmic therapeutics.

6 Sep 2012

F-18-FDG PET/CT may easily predict disease-free survival for invasive ductal breast cancer patients

Disease-free survival for invasive ductal breast cancer (IDC) patients may be easier to predict with the help of F-18-fludeoxyglucose positron emission tomography (PET)/computed tomography (CT) scans, according to research published in the September issue of The Journal of Nuclear Medicine. New data show that high maximum standard uptake value (SUVmax) of F-18-FDG in the lymph nodes prior to treatment could be an independent indicator of disease recurrence.

6 Sep 2012

LIN28 protein can bind directly to thousands of messenger RNAs

A study led by researchers at the UC San Diego Stem Cell Research program and funded by the California Institute for Regenerative Medicine (CIRM) looks at an important RNA binding protein called LIN28, which is implicated in pluripotency and reprogramming as well as in cancer and other diseases.

6 Sep 2012

Two UNC autism researchers receive $12.6 million in grants from ACE program

Two autism researchers in the University of North Carolina School of Medicine have each been awarded $12.6 million grants in the latest round of funding from the National Institutes of Health's Autism Centers of Excellence (ACE) research program.

6 Sep 2012

Janssen receives FDA Priority Review for bedaquiline NDA to treat MDR-TB

Janssen Research & Development, LLC (Janssen) announced today that the U.S. Food and Drug Administration (FDA) has granted Priority Review to the New Drug Application (NDA) for bedaquiline (TMC207) to treat pulmonary, multi-drug resistant tuberculosis (MDR-TB) in adults as part of combination therapy.

6 Sep 2012

Roundup: Cancer drug cost equity bill sitting on Calif. Gov's desk; Mass. cost-containment law could harm provider credit ratings

Out-of-pocket costs for cancer drugs can vary dramatically depending on whether the medications are administered through pill form or intravenous infusion. Newer oral drugs, which can be taken at home and often have fewer side effects than older drugs, can cost patients thousands of dollars a month, while receiving chemotherapy through an IV in an infusion center typically amounts to a standard co-payment for an office visit.

6 Sep 2012

Research News and Research

ACOEM awareness campaign helps employers identify and respond to chronic diseases

Patients at hospitals with longer resuscitation attempts have higher survival rates

Biologic therapies do not increase risk of cancer in patients with rheumatoid arthritis

Viewpoints: Anti-abortion Democrats praise health law; A defense of the Medicare cost-cutting board

UEA, IFR to study protective effects of broccoli consumption against prostate cancer

Study sheds new light on why most bone marrow transplant patients suffer acute GVHD

ImmunoCellular completes enrollment in ICT-107 Phase II trial for glioblastoma

Medicare beneficiaries who were overcharged for drugs because of CVS' incorrect prices will receive refunds

TSC and PTEN genes important in controlling blood precursor cells in Drosophila

Developing countries NGO delegation to Global Fund submits report highlighting challenges, recommendations

Nordion third quarter revenue increases 0.5% to $67.1 million

DuraSite 2 ophthalmic drug delivery system from InSite Vision

F-18-FDG PET/CT may easily predict disease-free survival for invasive ductal breast cancer patients

LIN28 protein can bind directly to thousands of messenger RNAs

Two UNC autism researchers receive $12.6 million in grants from ACE program

Janssen receives FDA Priority Review for bedaquiline NDA to treat MDR-TB

Roundup: Cancer drug cost equity bill sitting on Calif. Gov's desk; Mass. cost-containment law could harm provider credit ratings

Unemployment barrier to antidiabetic medication adherence

Predictors for pain after breast cancer surgery unveiled

Kidney stones signal poor renal prognosis

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery